• Tak Kyu Oh, Hyung-Ho Kim, Park Do Joong DJ Department of Surgery, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea., Sang-Hoon Ahn, Sang-Hwan Do, Jung-Won Hwang, Jin Hee Kim, Ah-Young Oh, Young-Tae Jeon, and In-Ae Song.
• Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea.
• Pain Pract. 2018 Jul 1; 18 (6): 729-735.

BackgroundOpioid usage is reportedly increased in patients with advanced cancer and low total cholesterol (TC). The aim of this study was to determine the effects of preoperative serum TC levels on postoperative opioid usage in patients undergoing laparoscopic gastric cancer surgery.MethodsWe retrospectively analyzed the medical records of patients with gastric cancer who underwent laparoscopic gastrectomy at our institution between January 1, 2011 and July 31, 2017. We investigated the correlation between TC levels in the month before surgery and numeric rating scale (NRS) scores and opioid consumption on postoperative days (PODs) 0 to 3. The patients were stratified according to preoperative TC level (< 160 mg/dL, low; 160 to 199 mg/dL, medium; ≥ 200 mg/dL, high).ResultsTC and NRS scores (PODs 0, 1) for 1,919 eligible patients showed weak but significant positive coefficients (0.074 and 0.098 on POD 0 and POD 1, respectively, P < 0.01). After adjusting for confounders, there were no significant differences in postoperative NRS scores on PODs 0, 1, 2, or 3 or in oral morphine equivalents on PODs 0 to 3 according to TC level.ConclusionPreoperative serum TC levels have no effect on pain outcomes in the 3 days following laparoscopic gastric surgery.© 2017 World Institute of Pain.

24 keywords...

hide…